Cite
HARVARD Citation
Pribyl, M. et al. (2020). Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes. Molecular oncology. 14 (10), pp. 2403-2419. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pribyl, M. et al. (2020). Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes. Molecular oncology. 14 (10), pp. 2403-2419. [Online].